Pancreatic Cancer Research

ResearcherShariati HospitalActive in the last 2 years

Hamid Reza Fazli

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5051447019. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Protective Effect of Dehydroepiandrosterone (DHEA) On Pancreatic Cancer Through C-Reactive Protein (CRP) Production Inhibition. Co-author DOI 10.61186/rbmb.13.2.174↗
  2. Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study. Co-author DOI 10.1002/jgh3.12604↗
  3. Diagnostic Significance of Serum Fatty Acid Synthase in Patients with Pancreatic Cancer. Co-author DOI 10.34172/mejdd.2021.214↗
  4. An Increased Level of Aryl Hydrocarbon Receptor in Patients with Pancreatic Cancer. Co-author DOI 10.15171/mejdd.2018.126↗
  5. Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer. Co-author DOI 10.1155/2013/738915↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashraf Mohamadkhani · 5 shared papers, 2013–2024 · strength 0.75
  2. Akram Pourshams · 5 shared papers, 2013–2024 · strength 0.75
  3. Mojtaba Jafarinia · 1 shared paper, 2024 · strength 0.28
  4. Sahar Masoudi · 2 shared papers, 2019–2021 · strength 0.25
  5. Mojtaba Jafari Niya · 1 shared paper, 2021 · strength 0.17
  6. Elnaz Naderi · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.